This inventor holds 1 USPTO granted patent. Top assignee: Beckman Research Institute, City of Hope. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Yvonne Cornejo: Innovator in Macrophage Modulation
Introduction
Yvonne Cornejo is a prominent inventor based in Ontario, CA (US). She has made significant contributions to the field of biomedical research, particularly in the modulation of macrophage activity. Her innovative work has the potential to impact the treatment of various diseases.
Latest Patents
Yvonne Cornejo holds a patent for "Compositions and methods of modulating macrophage activity." This patent discloses methods for treating diseases associated with macrophage activity, autoimmune diseases, inflammatory diseases, and cancers located in the intraperitoneal cavity. The method involves intraperitoneally administering a therapeutically effective amount of a nanoparticle composition or pharmaceutical composition. The invention includes a silica nanoparticle that is non-covalently bound to a plurality of nucleic acids, which has a net positive charge in the absence of these nucleic acids. Additionally, the pharmaceutical composition comprises a nanoparticle composition along with a pharmaceutically acceptable excipient.
Career Highlights
Yvonne Cornejo is affiliated with City of Hope, a leading research and treatment center. Her work at this institution has allowed her to focus on innovative solutions for complex medical challenges. With her expertise, she has contributed to advancing the understanding of macrophage-related diseases.
Collaborations
Yvonne has collaborated with notable colleagues, including Jacob Berlin and Tom Haber. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Yvonne Cornejo's contributions to the field of macrophage modulation exemplify her dedication to advancing medical science. Her innovative patent and work at City of Hope highlight her role as a key figure in biomedical research.